CRON Q4 2022 Earnings — Cronos Group Inc. Revenue & Financial Results | Market Cap Arena

CRONCronos Group Inc.

$983M

Q4 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$23M-29.8% YoY

Gross Profit

-$234,000-1.0% margin

Operating Income

-$37M-159.9% margin

Net Income

-$79M-344.5% margin

EPS (Diluted)

$-0.21

QoQ Revenue Growth

-18.8%

Cash Flow

Operating Cash Flow

-$24M

Free Cash Flow

-$25M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$72M

Stockholders' Equity

$1.1B

Cash & Equivalents

$765M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$23M	$33M	-29.8%
Gross Profit	-$234,000	$2M	-109.5%
Operating Income	-$37M	-$206M	+82.2%
Net Income	-$79M	-$169M	+53.3%

Revenue Segments

Cannabis Flower

$16M68%

Cannabis Extracts

$7M31%

Product and Service, Other

$153,0001%

Geographic Segments

CANADA

$15M65%

ISRAEL

$7M31%

UNITED STATES

$854,0004%